Japan Animal Referral Medical Center Co., Ltd. (TYO:6039)
Japan · Delayed Price · Currency is JPY 1,022.00
-9.00 (-0.87%)
Aug 6, 2026, 1:10 PM JST
TYO:6039 Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,142 | 720 | 491 | 533 | 423 |
Depreciation & Amortization | 588 | 570 | 464 | 411 | 241 |
Loss (Gain) From Sale of Assets | 4 | 1 | 17 | 22 | - |
Other Operating Activities | -325 | -155 | -240 | -153 | -129 |
Change in Accounts Receivable | -41 | -28 | -33 | -34 | 2 |
Change in Inventory | -4 | -7 | 15 | -40 | 15 |
Change in Accounts Payable | -14 | 99 | 33 | 8 | -12 |
Change in Other Net Operating Assets | 45 | 172 | 152 | 63 | 17 |
Operating Cash Flow | 1,395 | 1,372 | 899 | 810 | 557 |
Operating Cash Flow Growth | 1.68% | 52.61% | 10.99% | 45.42% | 10.52% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -2,349 | -954 | -1,040 | -728 | -601 |
Sale of Property, Plant & Equipment | - | - | 1 | - | - |
Cash Acquisitions | - | - | - | - | -784 |
Sale (Purchase) of Intangibles | -107 | -9 | -14 | -13 | - |
Investment in Securities | - | - | 100 | - | - |
Other Investing Activities | -30 | -31 | -32 | -43 | -40 |
Investing Cash Flow | -2,486 | -994 | -985 | -784 | -1,425 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 2,498 | - | - | - | - |
Long-Term Debt Issued | 288 | 300 | 490 | 625 | 1,376 |
Total Debt Issued | 2,786 | 300 | 490 | 625 | 1,376 |
Short-Term Debt Repaid | -460 | - | - | - | - |
Long-Term Debt Repaid | -642 | -681 | -609 | -572 | -529 |
Total Debt Repaid | -1,102 | -681 | -609 | -572 | -529 |
Net Debt Issued (Repaid) | 1,684 | -381 | -119 | 53 | 847 |
Issuance of Common Stock | - | 8 | 61 | 775 | 7 |
Repurchase of Common Stock | - | -172 | -327 | - | -120 |
Common Dividends Paid | -100 | -53 | - | - | - |
Other Financing Activities | -9 | -10 | -7 | -8 | -12 |
Financing Cash Flow | 1,575 | -608 | -392 | 820 | 722 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 1 | - | - | 1 | - |
Net Cash Flow | 485 | -230 | -478 | 847 | -146 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -954 | 418 | -141 | 82 | -44 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -15.41% | 7.92% | -3.30% | 2.12% | -1.48% |
Free Cash Flow Per Share | -73.82 | 32.23 | -10.14 | 6.60 | -3.62 |
Levered Free Cash Flow | -1,072 | 6.38 | -26.25 | 280.88 | -268.13 |
Unlevered Free Cash Flow | -1,049 | 22.63 | -14.38 | 291.5 | -260 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 38 | 26 | 18 | 17 | 12 |
Cash Income Tax Paid | 325 | 157 | 241 | 154 | 107 |
Change in Working Capital | -14 | 236 | 167 | -3 | 22 |